Truist Securities Maintains Hold on Medtronic, Lowers Price Target to $107

Benzinga · 12/18/2025 15:48
Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and lowers the price target from $110 to $107.